Nucleic acid continuous synthesis device and nucleic acid continuous synthesis method thereof

By designing a continuous nucleic acid synthesis device, the combined valve group and solid-phase synthesis column group can be used to achieve simultaneous synthesis of multiple nucleic acids, and the reaction is monitored online through PAT technology, the existing nucleic acid synthesizer has low production efficiency and low pump utilization rate. The problem is that efficient nucleic acid synthesis and equipment operation are achieved.

CN118976442APending Publication Date: 2024-11-19张磊
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411050461.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-01
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

The existing nucleic acid synthesizer can only synthesize one nucleic acid product in one operation, which has low production efficiency, high time cost, and low pump utilization rate, resulting in low equipment operation efficiency.

Method used

A continuous nucleic acid synthesis device is designed, including a liquid inlet unit, a reaction unit and a detection unit. By combining valve group and solid phase synthesis column group, a simultaneous synthesis of multiple nucleic acids is achieved, using PAT technology, UV detector and conductance detector online Monitor the reaction process, improving production efficiency and pump utilization.

Benefits of technology

It has achieved the synthesis of three different nucleic acid products at the same time, without cross-contamination, and the production efficiency has been increased to three times that of existing instruments. The pump utilization rate has been significantly improved. The synthesis steps can be monitored online, which has improved the operating efficiency and output of the equipment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118976442A_ABST
    Figure CN118976442A_ABST
Patent Text Reader

Abstract

The embodiment of the invention relates to a nucleic acid continuous synthesis device and a nucleic acid continuous synthesis method thereof, and belongs to the technical field of biological product equipment. The nucleic acid continuous synthesis device comprises a liquid inlet unit, a reaction unit and a detection unit, and the liquid inlet unit, the reaction unit and the detection unit are communicated in sequence; wherein the liquid inlet unit conveys different raw material liquids to the reaction unit, the reaction unit utilizes the different raw material liquids to complete corresponding steps of solid-phase synthesis and conveys product liquids generated by reaction to the detection unit, and the detection unit detects the product liquids so as to monitor the reaction process. The nucleic acid continuous synthesis device provided by the embodiment of the invention can be assembled with three solid-phase synthesis columns with different specifications at the same time, so that three different nucleic acids can be produced at the same time, and cross contamination is avoided; the same nucleic acid production can be carried out by using three solid-phase synthesis columns with the same specification, and the yield in the same time is three times that of the existing nucleic acid synthesizer.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The embodiments of the present application relate to the technical field of biological product equipment, and in particular, to a nucleic acid continuous synthesis device and a nucleic acid continuous synthesis method thereof. Background Art

[0002] Small nucleic acid drugs are usually synthesized by solid phase synthesis, and the solid phase synthesis cycle consists of four steps: deprotection, coupling, oxidation / sulfurization, and capping. However, the nucleic acid synthesizers currently on the market have the following shortcomings: 1. Only one nucleic acid product can be synthesized in one operation, with low production efficiency and high time cost; 2. When the nucleic acid synthesizers on the market are running, the pump is in a stopped state for a long time, and the pump utilization rate is not high. Summary of the invention

[0003] In view of this, the embodiments of the present application provide a nucleic acid continuous synthesis device and a nucleic acid continuous synthesis method thereof to solve the technical problems raised in the background technology.

[0004] A first aspect of an embodiment of the present application provides a nucleic acid continuous synthesis device, the nucleic acid continuous synthesis device comprising a liquid inlet unit, a reaction unit and a detection unit, wherein the liquid inlet unit, the reaction unit and the detection unit are sequentially connected and arranged;

[0005] Among them, the liquid inlet unit transports different raw material liquids to the reaction unit, the reaction unit uses different raw material liquids to complete the corresponding steps of solid phase synthesis, and transports the product liquid generated by the reaction to the detection unit, and the detection unit detects the product liquid to monitor the reaction progress.

[0006] In some embodiments that may include the above embodiments, the reaction unit includes a combination valve group and a solid phase synthesis column group, the solid phase synthesis column group is connected to the combination valve group through a pipeline, and the reaction unit transports the different raw material liquids to the solid phase synthesis column group through the combination valve group.

[0007] In some embodiments that may include the above embodiments, the solid phase synthesis column group includes solid phase synthesis column A, solid phase synthesis column B and solid phase synthesis column C, and the solid phase synthesis column A, solid phase synthesis column B and solid phase synthesis column C are respectively connected to the combination valve group through pipelines.

[0008] In some embodiments that may include the above embodiments, the liquid inlet unit includes a first delivery flow path, a second delivery flow path and a third delivery flow path, and the first delivery flow path, the second delivery flow path and the third delivery flow path respectively deliver different raw material liquids to the reaction unit, and the first delivery flow path, the second delivery flow path and the third delivery flow path are respectively connected to the combination valve group by pipelines.

[0009] In some embodiments that may include the above embodiments, the first delivery flow path includes a liquid inlet valve A and a liquid inlet valve B, the liquid inlet valve A and the liquid inlet valve B are connected, and a coupling pump is provided between the liquid inlet valve B and the combined valve group; or

[0010] The second delivery flow path includes a liquid inlet valve C, and a deprotection pump is provided between the liquid inlet valve C and the combined valve group; or

[0011] The third delivery flow path includes a liquid inlet valve D and a liquid inlet valve E. The branch pipes of the liquid inlet valve D and the liquid inlet valve E respectively intersect at one path and are connected to the combined valve group, and a cap pump is provided between the intersection and the combined valve group.

[0012] In some embodiments that may include the above embodiments, the liquid inlet valve A, liquid inlet valve B, liquid inlet valve C, deprotection pump, liquid inlet valve D and liquid inlet valve E are all connected to the nitrogen valve through a pipeline.

[0013] In some embodiments that may include the above-mentioned embodiments, the detection unit includes a first detection channel, a second detection channel and a third detection channel, and the first detection channel, the second detection channel and the third detection channel are respectively connected to the combination valve group through pipelines, and the first detection channel, the second detection channel and the third detection channel respectively detect different product liquids produced by the reaction of the solid phase synthesis column group to detect the reaction progress.

[0014] In some embodiments that may include the above embodiments, the first detection channel, the second detection channel and the third detection channel respectively include a UV detector, a conductivity detector and an outlet valve that are connected in sequence, and a two-position three-way valve is arranged between the conductivity detector and the outlet valve of one of the detection channels, and the two-position three-way valve pipeline is connected to the liquid inlet valve B.

[0015] A second aspect of an embodiment of the present application further provides a method for continuous nucleic acid synthesis, which comprises using the above-mentioned continuous nucleic acid synthesis device to continuously synthesize nucleic acids.

[0016] Compared with the prior art, the embodiments of the present application have the following beneficial effects:

[0017] 1. The nucleic acid continuous synthesis device in the embodiment of the present application can be equipped with three solid phase synthesis columns of different specifications at the same time to achieve the production of three different nucleic acids at the same time without cross contamination;

[0018] 2. The nucleic acid continuous synthesis device in the embodiment of the present application can also use three solid phase synthesis columns of the same specification to produce the same nucleic acid, and the output in the same time is three times that of the existing nucleic acid synthesizer;

[0019] 3. The nucleic acid continuous synthesis device in the application example uses PAT technology to monitor the reaction degree of each synthesis step online through a UV detector and a conductivity detector. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] In order to more clearly illustrate the embodiments of the present application or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some embodiments of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative work.

[0021] Figure 1 Schematic diagram of the structure of the continuous nucleic acid synthesis device according to an embodiment of the present application.

[0022] Description of reference numerals:

[0023] 1. Liquid inlet valve A; 2. Liquid inlet valve B; 3. Coupling pump; 4. Liquid inlet valve C; 5. Deprotection pump; 6. Liquid inlet valve D; 7. Liquid inlet valve E; 8. Capping pump; 9. Combined valve group; 10. Solid phase synthesis column A; 11. Solid phase synthesis column B; 12. Solid phase synthesis column C; 13. UV detector; 14. Conductivity detector; 15. Two-position three-way valve; 16. Outlet valve; 17. Nitrogen valve. DETAILED DESCRIPTION

[0024] In order to make the purpose, technical solution and advantages of the embodiments of the present application clearer, the technical solution in the embodiments of the present application will be clearly and completely described below in conjunction with the drawings in the embodiments of the present application. Obviously, the described embodiments are part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of this application.

[0025] First, those skilled in the art should understand that these implementations are only used to explain the technical principles of the present application and are not intended to limit the scope of protection of the present application. Those skilled in the art can make adjustments to them as needed to adapt to specific application scenarios.

[0026] Secondly, it should be noted that in the description of the present application, terms such as "up", "down", "left", "right", "front", "back", "inside" and "outside" indicating directions or positional relationships are based on the directions or positional relationships shown in the drawings. This is merely for the convenience of description and does not indicate or imply that the device or component must have a specific orientation, be constructed and operated in a specific orientation. Therefore, it should not be understood as a limitation on the present application.

[0027] The nucleic acid synthesizers currently on the market in the related art have the following shortcomings: 1. Only one nucleic acid product can be synthesized in one operation, with low production efficiency and high time cost; 2. When the nucleic acid synthesizers on the market are running, the pump is in a stopped state for a long time, and the pump utilization rate is not high.

[0028] Example 1

[0029] In order to solve the above technical problems, Figure 1 As shown, an embodiment of the present application provides a nucleic acid continuous synthesis device, which includes a liquid inlet unit, a reaction unit and a detection unit, and the liquid inlet unit, the reaction unit and the detection unit are connected in sequence.

[0030] Among them, the liquid inlet unit transports different raw material liquids to the reaction unit, the reaction unit uses different raw material liquids to complete the corresponding steps of solid phase synthesis, and transports the product liquid generated by the reaction to the detection unit, and the detection unit detects the product liquid to monitor the reaction progress.

[0031] Specifically, the liquid inlet unit includes an inlet valve A1, and the type of the inlet valve A1 is an eight-in-one-out valve. Exemplarily, the inlet valve A1 is an inlet valve for nucleotides and acetonitrile; the liquid inlet unit also includes an inlet valve B2, and the type of the inlet valve B2 is a quaternary proportional valve. Exemplarily, the inlet valve B2 is an inlet valve for an activator, acetonitrile and diethylamine; the liquid inlet unit also includes a coupling pump 3 for transporting reagents from the inlet valve A1 and the inlet valve B2; the liquid inlet unit also includes an inlet valve C4, and the type of the inlet valve C4 is a four-in-one-out valve. Exemplarily, the inlet valve C4 is an inlet valve for a deprotecting agent, acetonitrile and diethylamine; the liquid inlet unit also includes a deprotection pump 5 for transporting a deprotecting agent, acetonitrile and diethylamine; the liquid inlet unit also includes an inlet valve D6, and the type of the inlet valve D6 is a four-in-one-out valve. Exemplarily, the inlet valve D 6 is an inlet valve for the oxidant, the sulfiding agent and the acetonitrile; the inlet unit also includes an inlet valve E 7, and the inlet valve E 7 is a quaternary proportional valve. Exemplarily, the inlet valve E 7 is an inlet valve for CapA, Cap B, diethylamine and acetonitrile; the inlet unit also includes a cap pump 8, and the cap pump 8 is used to transport the oxidant, the sulfiding agent, CapA, Cap B, diethylamine and acetonitrile.

[0032] Specifically, the reaction unit includes a combination valve group 9 and a solid phase synthesis column group. The solid phase synthesis column group is connected to the combination valve group 9 through a pipeline. The reaction unit transports different raw material liquids to the solid phase synthesis column group through the combination valve group 9.

[0033] In a specific embodiment, the solid phase synthesis column group includes solid phase synthesis column A10, solid phase synthesis column B11 and solid phase synthesis column C12, and the solid phase synthesis column A10, solid phase synthesis column B11 and solid phase synthesis column C12 are respectively connected to the combined valve group 9 through pipelines.

[0034] In a specific embodiment, the liquid inlet unit includes a first delivery flow path, a second delivery flow path and a third delivery flow path, and the first delivery flow path, the second delivery flow path and the third delivery flow path respectively deliver different raw material liquids to the reaction unit, and the first delivery flow path, the second delivery flow path and the third delivery flow path are respectively connected to the combination valve group 9 by pipelines.

[0035] In a specific embodiment, the first delivery flow path includes an inlet valve A1 and an inlet valve B2, the inlet valve A1 and the inlet valve B2 are connected, and a coupling pump 3 is arranged between the inlet valve B2 and the combination valve group 9; the second delivery flow path includes an inlet valve C4, and a deprotection pump 5 is arranged between the inlet valve C4 and the combination valve group 9; the third delivery flow path includes an inlet valve D6 and an inlet valve E7, and the branch pipes of the inlet valve D6 and the inlet valve E7 are respectively intersected into one way and connected to the combination valve group 9, and a cap pump 8 is arranged between the intersection of the inlet valve D6 and the inlet valve E7 and the combination valve group 9.

[0036] In a specific implementation, the liquid inlet valve A1, the liquid inlet valve B2, the liquid inlet valve C4, the deprotection pump 5, the liquid inlet valve D6 and the liquid inlet valve E7 are all connected to the nitrogen valve 17 through a pipeline.

[0037] In a specific embodiment, the detection unit includes a first detection channel, a second detection channel and a third detection channel, and the first detection channel, the second detection channel and the third detection channel are respectively connected to the combination valve group 9 through pipelines, and the first detection channel, the second detection channel and the third detection channel respectively detect different product liquids produced by the reaction of the solid phase synthesis column group to detect the reaction progress.

[0038] Specifically, the first detection channel, the second detection channel and the third detection channel respectively include a UV detector 13, a conductivity detector 14 and an outlet valve 16 which are connected in sequence, and a two-position three-way valve 15 is arranged between the conductivity detector 14 and the outlet valve 16 of one of the detection channels, and the two-position three-way valve 15 is connected to the liquid inlet valve B2 through a pipeline.

[0039] Example 2

[0040] This embodiment provides a method for continuous synthesis of nucleic acids, which is to use the continuous nucleic acid synthesis device in Example 1 to continuously synthesize nucleic acids, and specifically comprises the following steps:

[0041] (1) Cleaning the pipeline of the nucleic acid continuous synthesis device with acetonitrile, replacing the gas in the pipeline with acetonitrile, installing the solid phase synthesis column A10, the solid phase synthesis column B11 and the solid phase synthesis column C12 on the combined valve group 9, and flushing the solid phase synthesis column A10, the solid phase synthesis column B11 and the solid phase synthesis column C12 with acetonitrile;

[0042] (2) Place the inlet pipes of inlet valve A1, inlet valve B2, inlet valve C4, inlet valve D6, and inlet valve E7 into the corresponding reagent bottles;

[0043] (3) Open the nitrogen valve 17 to pass nitrogen into all reagent bottles and maintain a positive pressure of 0.3 to 0.35 bar to prevent moisture in the environment from entering the reagent bottles;

[0044] (4) Open one of the inlets of liquid inlet valve A1, liquid inlet valve B2, liquid inlet valve C4, liquid inlet valve D6, and liquid inlet valve E7, and correspondingly open one of the coupling pump 3, deprotection pump 5, or capping pump 8 to replace the gas in the pipeline with the reagent in a single reagent bottle;

[0045] (5) the deprotecting agent enters the solid phase synthesis column A10 at a certain flow rate, and after reaching the inlet volume, the solid phase synthesis column A10 is rinsed with acetonitrile;

[0046] (6) The two-position three-way valve 15 is changed to connect the outlet valve 16, and the nucleotide and the activator enter the solid phase synthesis column A10 at a certain ratio and flow rate. After reaching the inlet volume, the inlet of the inlet valve A1 is changed to acetonitrile, and the material in the pipeline is top-washed into the solid phase synthesis column A10, and the coupling pump 3 is stopped;

[0047] (7) The two-position three-way valve 15 is changed to connect to the liquid inlet valve B2 passage, the coupling pump 3 is operated at a certain flow rate, and the reaction degree is confirmed by the changes of the UV detector 13 and the conductivity detector 14;

[0048] (8) After the reaction is completed, the two-position three-way valve 15 is changed to connect the outlet valve 16, and the inlet of the inlet valve A1 is changed to acetonitrile, and acetonitrile is used to rinse the solid phase synthesis column A10;

[0049] (9) Selecting an oxidant or sulfiding agent inlet according to the process, introducing the oxidant or sulfiding agent into one of the solid phase synthesis column A10, solid phase synthesis column B11 or solid phase synthesis column C12 at a certain flow rate, and after reaching a certain volume, changing the inlet to acetonitrile, top-washing the material in the pipeline into one of the solid phase synthesis column A10, solid phase synthesis column B11 or solid phase synthesis column C12, and then washing the solid phase synthesis column A10 with acetonitrile;

[0050] (10) The inlet is changed to the liquid inlet valve B2, and CapA and Cap B are introduced into one of the solid phase synthesis column A10, solid phase synthesis column B11 or solid phase synthesis column C12 at a certain ratio and flow rate. After reaching a certain volume, the inlet is changed to acetonitrile, and the material in the pipeline is top-washed into one of the solid phase synthesis column A10, solid phase synthesis column B11 or solid phase synthesis column C12, and then the solid phase synthesis column A10 is rinsed with acetonitrile;

[0051] (11) Steps (5) to (10) constitute a coupling cycle. During the first cycle, solid phase synthesis column A10 performs step (5). After completion, combination valve group 9 is switched, solid phase synthesis column A10 performs steps (6) to (8), and solid phase synthesis column B11 performs step (5). After completion, combination valve group 9 is switched, solid phase synthesis column A10 performs steps (9) to (10), and solid phase synthesis column B11 performs steps (6) to (8), and solid phase synthesis column C12 performs step (5);

[0052] (12) In the non-first cycle operation, the three solid phase synthesis columns run different steps at the same time. For example, at one time point, the liquid in the deprotection pump 5 enters the solid phase synthesis column A10, the liquid in the coupling pump 3 enters the solid phase synthesis column B11, and the liquid in the capping pump 8 enters the solid phase synthesis column C12. After these three steps are completed at the same time, the combination valve group 9 is switched, and the liquid in the deprotection pump 5 enters the solid phase synthesis column C12, the liquid in the coupling pump 3 enters the solid phase synthesis column A10, and the liquid in the capping pump 8 enters the solid phase synthesis column B11. After completion, the combination valve group 9 is switched to continue to run the subsequent steps;

[0053] (13) After all the synthesis reactions are completed, the inlet is changed to diethylamine, which is simultaneously introduced into three solid phase synthesis columns at a certain flow rate for post-treatment reaction. After a certain period of time, the inlet is changed to acetonitrile, and the three solid phase synthesis columns are simultaneously flushed;

[0054] (14) After the post-treatment step, the filler in the solid phase synthesis column that has completed the synthesis is recovered and the subsequent steps are carried out;

[0055] (15) Rinse the pipeline of the nucleic acid continuous synthesis device with acetonitrile and store it.

[0056] Example 3

[0057] This embodiment provides a method for continuous synthesis of siRNA, which is to use the nucleic acid continuous synthesis device in Example 1 to continuously synthesize three siRNAs with different sequences, and specifically comprises the following steps:

[0058] (1) Clean the pipeline of the nucleic acid continuous synthesis device with acetonitrile, replace the gas in the pipeline with acetonitrile, connect three solid phase synthesis columns A10, B11 and C12 filled with 6.3 ml of DMT-dA bonded phase filler to the combined valve group 9, and flush the three solid phase synthesis columns A10, B11 and C12 with acetonitrile at a flow rate of 10 ml / min for 12.6 ml;

[0059] (2) Place the inlet tube of the inlet valve A1 in sequence into the reagent bottles of DMT-dA, acetonitrile, DMT-dU, acetonitrile, DMT-dC, acetonitrile, DMT-dG, and acetonitrile; place the inlet tube of the inlet valve B2 in the reagent bottles of the activator, acetonitrile, diethylamine, and acetonitrile respectively, and connect the remaining inlet to the inlet valve A1; place the inlet tube of the inlet valve C4 in sequence into the reagent bottles of the deprotecting agent, acetonitrile, diethylamine, and acetonitrile; place the inlet tube of the inlet valve D6 in sequence into the reagent bottles of the oxidant, acetonitrile, sulfiding agent, and acetonitrile; place the inlet tube of the inlet valve E7 in sequence into the reagent bottles of CapA, Cap B, diethylamine, and acetonitrile;

[0060] (3) Open the nitrogen valve 17, pass nitrogen into all reagent bottles, and maintain a positive pressure of 0.3 to 0.35 bar to prevent moisture in the environment from entering the reagent bottles;

[0061] (4) Open one of the inlets of liquid inlet valve A1, liquid inlet valve B2, liquid inlet valve C4, liquid inlet valve D6, and liquid inlet valve E7, and correspondingly open one of the coupling pump 3, the deprotection pump 5, or the capping pump 8 to replace the liquid in the pipeline with the reagent in a single reagent bottle;

[0062] (5) The deprotecting agent enters the solid phase synthesis column A10 at a flow rate of 20.93 ml / min, 7.56 ml of liquid is introduced, and then the solid phase synthesis column A10 is flushed with acetonitrile at a flow rate of 10 ml / min for 5.14 min;

[0063] (6) The two-position three-way valve 15 is changed to connect the outlet valve 16, and DMT-dU at a ratio of 40% and the activator at a ratio of 50% at a flow rate of 8.3 ml / min enters the solid phase synthesis column A10, and 2.14 ml of liquid is continuously fed. Then the inlet of the liquid inlet valve A1 is changed to acetonitrile, and 2 ml of top washing is performed at 8.3 ml / min. The material in the pipeline is pushed into the solid phase synthesis column A10, and the coupling pump 3 is stopped;

[0064] (7) The two-position three-way valve 15 is changed to connect to the liquid inlet valve B2 passage, and the coupling pump 3 is operated at a flow rate of 8.3 ml / min. When the UV detector 13 and the conductivity detector 14 do not change, the reaction is completed, and the continuous operation time is about 3 min;

[0065] (8) After the reaction is completed, the two-position three-way valve 15 is changed to connect the outlet valve 16, and the inlet of the inlet valve A1 is changed to acetonitrile. Acetonitrile is used to flush the solid phase synthesis column A10 at 10 ml / min for 10.4 ml;

[0066] (9) Select the oxidant or sulfiding agent inlet according to the process. If the oxidant is selected, the oxidant is introduced into the solid phase synthesis column A10 at a flow rate of 10.4 ml / min for 10.4 ml; if the sulfiding agent is selected, the sulfiding agent is introduced into the solid phase synthesis column A10 at a flow rate of 2.1 ml / min for 6.3 ml; after the oxidation or sulfidation is completed, change the inlet to acetonitrile, top wash 2 ml at 10 ml / min, top wash the material in the pipeline into the solid phase synthesis column A10, and then rinse the solid phase synthesis column A10 with acetonitrile at a flow rate of 10 ml / min. The oxidation step continues to rinse 26.33 ml, and the sulfidation step continues to rinse 12.6 ml;

[0067] (10) The inlet is changed to the liquid inlet valve B2, and CapA and Cap B are introduced into the solid phase synthesis column A10 at a flow rate of 50% and 6.3 ml / min, and 6.3 ml of liquid is continuously introduced. After completion, the inlet is changed to acetonitrile, and 2 ml of the material in the pipeline is top-washed into the solid phase synthesis column A10 at a flow rate of 10 ml / min. The solid phase synthesis column A10 is then rinsed with acetonitrile at a flow rate of 10 ml / min, and 18.9 ml of the liquid is continuously rinsed;

[0068] (11) Steps (5) to (10) constitute a coupling cycle. During the first cycle, solid phase synthesis column A10 performs step (5). After completion, combination valve group 9 is switched, solid phase synthesis column A10 performs steps (6) to (8), and solid phase synthesis column B11 performs step (5). After completion, combination valve group 9 is switched, solid phase synthesis column A10 performs steps (9) to (10), and solid phase synthesis column B11 performs steps (6) to (8), and solid phase synthesis column C12 performs step (5);

[0069] (12) In non-first cycle operation, the three solid phase synthesis columns simultaneously run different steps. For example, at a time point during the synthesis process, the liquid in the deprotection pump 5 enters the solid phase synthesis column A10, the liquid in the coupling pump 3 enters the solid phase synthesis column B11, and the liquid in the capping pump 8 enters the solid phase synthesis column C12. When these three steps are completed at the same time, the combination valve group 9 is switched, and the liquid in the deprotection pump 5 enters the solid phase synthesis column C12, the liquid in the coupling pump 3 enters the solid phase synthesis column A10, and the liquid in the capping pump 8 enters the solid phase synthesis column B11. After completion, the combination valve group 9 is switched to continue running the subsequent steps;

[0070] (13) After all the sequential synthesis reactions were completed, the inlet was changed to diethylamine, which was simultaneously introduced into three solid phase synthesis columns at a flow rate of 2 ml / min for post-treatment reaction, which lasted for 10 min. After completion, the inlet was changed to acetonitrile, and the three solid phase synthesis columns were simultaneously flushed at a flow rate of 10 ml / min;

[0071] (14) After the post-treatment step, the filler in the solid phase synthesis column that has completed the synthesis is recovered and the subsequent steps are carried out;

[0072] (15) The nucleic acid continuous synthesis apparatus was flushed with acetonitrile at 10 ml / min for 2 min and then stored.

[0073] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present application, rather than to limit it. Although the present application has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present application.

Claims

1. A nucleic acid continuous synthesis device, characterized in that: The nucleic acid continuous synthesis device comprises a liquid inlet unit, a reaction unit and a detection unit, and the liquid inlet unit, the reaction unit and the detection unit are connected and arranged in sequence; Among them, the liquid inlet unit transports different raw material liquids to the reaction unit, the reaction unit uses different raw material liquids to complete the corresponding steps of solid phase synthesis, and transports the product liquid generated by the reaction to the detection unit, and the detection unit detects the product liquid to monitor the reaction progress.

2. The nucleic acid continuous synthesis device according to claim 1, characterized in that: The reaction unit comprises a combined valve group (9) and a solid phase synthesis column group, the solid phase synthesis column group is connected to the combined valve group (9) via a pipeline, and the reaction unit transports the different raw material liquids to the solid phase synthesis column group via the combined valve group (9).

3. The nucleic acid continuous synthesis device according to claim 2, characterized in that: The solid phase synthesis column group comprises a solid phase synthesis column A (10), a solid phase synthesis column B (11) and a solid phase synthesis column C (12); the solid phase synthesis column A (10), the solid phase synthesis column B (11) and the solid phase synthesis column C (12) are respectively connected to the combined valve group (9) through pipelines.

4. The nucleic acid continuous synthesis device according to claim 2, characterized in that: The liquid inlet unit comprises a first conveying flow path, a second conveying flow path and a third conveying flow path, wherein the first conveying flow path, the second conveying flow path and the third conveying flow path respectively convey different raw material liquids to the reaction unit, and the first conveying flow path, the second conveying flow path and the third conveying flow path are respectively connected to the combined valve group (9) through pipelines.

5. The nucleic acid continuous synthesis device according to claim 4, characterized in that: The first delivery flow path comprises a liquid inlet valve A (1) and a liquid inlet valve B (2), the liquid inlet valve A (1) and the liquid inlet valve B (2) are arranged in communication, and a coupling pump (3) is arranged between the liquid inlet valve B (2) and the combined valve group (9); or The second delivery flow path includes a liquid inlet valve C (4), and a deprotection pump (5) is provided between the liquid inlet valve C (4) and the combined valve group (9); or The third delivery flow path comprises a liquid inlet valve D (6) and a liquid inlet valve E (7), wherein the branch pipes of the liquid inlet valve D (6) and the liquid inlet valve E (7) respectively intersect at one path and are connected to the combined valve group (9), and a cap pump (8) is provided between the intersection and the combined valve group (9).

6. The nucleic acid continuous synthesis device according to claim 5, characterized in that: The liquid inlet valve A (1), the liquid inlet valve B (2), the liquid inlet valve C (4), the deprotection pump (5), the liquid inlet valve D (6) and the liquid inlet valve E (7) are all connected to the nitrogen valve (17) through pipelines.

7. The nucleic acid continuous synthesis device according to claim 5, characterized in that: The detection unit comprises a first detection channel, a second detection channel and a third detection channel, wherein the first detection channel, the second detection channel and the third detection channel are respectively connected to the combined valve group (9) through pipelines, and the first detection channel, the second detection channel and the third detection channel respectively detect different product liquids generated by the reaction of the solid phase synthesis column group to detect the reaction progress.

8. The nucleic acid continuous synthesis device according to claim 7, characterized in that: The first detection channel, the second detection channel and the third detection channel respectively comprise a UV detector (13), a conductivity detector (14) and an outlet valve (16) which are connected in sequence, and a two-position three-way valve (15) is arranged between the conductivity detector (14) and the outlet valve (16) of one of the detection channels, and a pipeline of the two-position three-way valve (15) is connected to the liquid inlet valve B (2).

9. A method for continuous nucleic acid synthesis, characterized in that: The method comprises the step of continuously synthesizing nucleic acid using the nucleic acid continuous synthesis device according to any one of claims 1 to 8.